Skip to main content
Displaying 1 - 12 of 23
Display:
12
24
48
Metabolism, Alcohol & Toxicity
AKH Inc., Advancing Knowledge in Healthcare: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best ...
Webcasts
View
Metabolism, Alcohol & Toxicity
Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy
Webcasts
View
Metabolism, Alcohol & Toxicity
Integrating MASLD/MASH-Specific Therapy into Guideline-Aligned Real-World Practice
Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A
Webcasts
View
Metabolism, Alcohol & Toxicity
Changing the MASH Paradigm With THR-β Agonists and Other Disease-Specific Therapies
Webcasts
View
Metabolism, Alcohol & Toxicity
AKH: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration (Comp...
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Albireo Pharma, an Ipsen Company: “New Horizons in cholestatic liver disease” (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Madrigal Pharmaceuticals: "Emerging role of the hepatic thyroid pathway in the pathophysiology of NASH" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Discussion and Q&A
Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
NASH: a growing unmet therapeutic need
Webcasts
View
Metabolism, Alcohol & Toxicity
The underestimated role of thyroid hormone pathway in the pathophysiology of NASH
Webcasts
View
Pagination
Current page
1
Page
2
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy